Project XY: Genome Insights
One test, lifespan healthcare planning
Test whole genome sequence once and receive up-to-date, actionable genome-based healthcare reports during the whole lifetime
As more and more disease-gene relationships are discovered, genome-based healthcare reports shouldn’t be a one-time service, especially when the human reference genome is kept updating.
Based on the ultra-fast and fully automated end-to-end genome analysis pipeline, GeneASIC offers genome analytics reports annually with the latest disease-gene information once WGS is performed.
Inside the black box
The disease risk assessment of gene variants can be updated regularly by our automated, end-to-end NGS analysis solution, consisting of GeneASIC NGSAAP and Holmes. As fully local computing, genomic data is completely protected.
An ultra-fast NGS analysis platform
GeneASIC NGSAAP is an on-premise platform that completes 30X WGS secondary analysis within 30 minutes.
An automated pathogenic mutation classifier
Holmes automates the pathogenicity identification process based on the refined ACMG/AMP variant classification criteria – SHERLOC.